| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/05/2011 | EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands |
| 01/05/2011 | EP2269994A1 The polymorphs of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof |
| 01/05/2011 | EP2269993A1 2-aminoquinazoline derivative |
| 01/05/2011 | EP2269992A1 Bicyclic pyrimidinones for the treatment of viral infections |
| 01/05/2011 | EP2268635A1 Heterocyclic compounds |
| 01/05/2011 | EP2268625A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof |
| 01/05/2011 | EP2268623A1 Quinazoline derivatives as raf kinase modulators and methods of use thereof |
| 01/05/2011 | EP2268622A1 Regioselective preparation of substituted pyrimidines |
| 01/05/2011 | EP2268621A1 Regioselective preparation of substituted pyrimidines |
| 01/05/2011 | EP2268144A2 Diaminopyrimidines as plant protection agents |
| 01/05/2011 | EP1824489B1 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 01/05/2011 | EP1633726B1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2 |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | CN101939303A Novel crystalline forms |
| 01/05/2011 | CN101939302A Mesoionic pesticides |
| 01/05/2011 | CN101939301A Process for preparing bosentan |
| 01/05/2011 | CN101938905A Chemical compounds |
| 01/05/2011 | CN101935317A Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof |
| 01/05/2011 | CN101935304A Rosuvastatin glycine tert-butyl ester salt and preparation method thereof |
| 01/05/2011 | CN101570516B Method for preparing 4-(3-chlorine-4-fluorophenylalanine)-7-methoxy-6-[3-(4-morpholinyl) propoxy] quinazoline |
| 01/05/2011 | CN101177415B Method for preparing new crystal form of anti-cancer compound ZD1839 |
| 01/04/2011 | US7863446 Heterocycles |
| 01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 01/04/2011 | US7863428 Fluorogenic enzyme substrates and methods of preparation |
| 01/04/2011 | US7863333 asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis; Azetidine-1-carboxylic acid {2-[({2-hydroxy-1-[(isopropyl-methyl-amino)-methyl]-pentylcarbamoyl}-methyl)-carbamoyl]-4-trifluoromethyl-phenyl}-amide |
| 01/04/2011 | US7863317 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| 01/04/2011 | US7863313 Methods for the treatment of inflammatory diseases |
| 01/04/2011 | US7863286 (1R,2R,3S,4S) N4-(3-Aminocarbonylbicyclo[2.2.1]hept-5-ene-2-yl)-5-fluoro-N2-[3-(1,3-oxazol-2-yl)phenyl]-2,4-pyrimidinediamine, exhibiting antiproliferative, anticarcinogenic or antitumor activity |
| 01/04/2011 | US7863284 such as N-{N-{4-[N-(2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamic acid, used for aiding regression and palliation of ovarian cancer; antiproliferative agents |
| 01/04/2011 | US7863281 4-[(3-chloro-4-fluoro-phenyl)amino]-6-{[4-((1S,4S)-2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-1-oxo-2-buten-1-yl]amino}-7-cyclopropylmethoxy-quinazoline; inhibitor of signal transduction mediated by tyrosine kinases; antitumor agent; benign prostatic hyperplasia, lungs and respiratory tract disease; bile duct |
| 01/04/2011 | US7863264 Complex of silver and ligand; bactericides, viricides, fungicides |
| 01/04/2011 | US7863220 Herbicidal pyrimidines |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2425531C Process for producing substituted aniline compounds from acetanilides |
| 01/04/2011 | CA2413426C Methods and compositions utilizing quinazolinones |
| 01/04/2011 | CA2319672C Compounds and compositions for delivering active agents |
| 12/30/2010 | US20100331351 Methods and compositions for treating bacterial infection |
| 12/30/2010 | US20100331334 Inhibitors of mek |
| 12/30/2010 | US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors |
| 12/30/2010 | US20100331294 4-substituted-2-amino-pyrimidine derivatives |
| 12/30/2010 | US20100330032 Heterocyclic antiviral compounds |
| 12/30/2010 | US20100330030 Vasculostatic Agents and Methods of Use Thereof |
| 12/30/2010 | US20100329998 Novel heterocycles |
| 12/30/2010 | US20100328600 Liquid crystal compound, liquid crystal composition and liquid crystal display device |
| 12/29/2010 | WO2010151710A2 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof |
| 12/29/2010 | WO2010151644A2 Antineoplastic hydrogels, and enzyme-instructed preparations thereof |
| 12/29/2010 | WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 12/29/2010 | WO2010150279A2 Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor |
| 12/29/2010 | WO2010148631A1 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof |
| 12/29/2010 | WO2010129848A3 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides |
| 12/29/2010 | EP2266977A1 2,4-di[(hetero)arylamino]-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 12/29/2010 | EP2266963A1 Fluorogenic peptidase substrate |
| 12/29/2010 | EP2266962A1 The compounds as the estrogen related receptors modulators and the uses thereof |
| 12/29/2010 | EP2266540A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 12/29/2010 | EP2265626A2 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 12/29/2010 | EP1940826B1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 12/29/2010 | EP1430018B1 Method for producing beta-alanine amides |
| 12/29/2010 | CN101932565A Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor |
| 12/29/2010 | CN101932564A Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 12/29/2010 | CN101926802A Application of quinazoline compounds |
| 12/29/2010 | CN101423499B Method for preparing high purity 4,6-dimethoxy-2-((phenoxy carbonyl)amido)-pyrimidine |
| 12/29/2010 | CN101100459B Method for preparing (E)-3-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-prop-2-en-1-ol, intermediate thereof and preparation method for the intermediate |
| 12/29/2010 | CA2762675A1 Heterocyclic antiviral compound |
| 12/28/2010 | US7858784 use with low catalyst loadings for various reactions such as arylation of methylamine; ligand such as 2-dicyclohexylphosphino-3,6-dimethoxy-2',4',6'-triisopropylbiphenyl |
| 12/28/2010 | US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 12/28/2010 | US7858633 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 12/28/2010 | US7858632 Purinergic receptor antagonists; genitourinary and pain-related diseases; for example, 5-(2-isopropyl-4,5-dimethoxybenzyl)-pyrimidine-2,4-diamine |
| 12/28/2010 | US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes |
| 12/28/2010 | US7858626 Pyrimidineamines as angiogenesis modulators |
| 12/28/2010 | US7858211 Organic electroluminescent device |
| 12/23/2010 | WO2010146164A1 Fluorogenic peptidase substrate |
| 12/23/2010 | WO2010146132A1 Sulfonamides and sulfamides as zap-70 inhibitors |
| 12/23/2010 | WO2010144959A1 Analogues of anti-fibrotic agents |
| 12/23/2010 | WO2010091876A3 Small molecule bradykinin b1 receptor antagonists |
| 12/23/2010 | US20100324289 Chemical Process |
| 12/23/2010 | US20100324093 Ccr9 inhibitors and methods of use thereof |
| 12/23/2010 | US20100324045 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 12/23/2010 | US20100324025 Antibacterial Agents |
| 12/23/2010 | US20100324001 Novel Methods for the Treatment of Inflammatory Diseases |
| 12/23/2010 | US20100323896 Use of sulfonanilides as herbicide |
| 12/23/2010 | US20100322980 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2 |
| 12/23/2010 | CA2763720A1 Sulfonamides and sulfamides as zap-70 inhibitors |
| 12/22/2010 | EP2264023A1 Method for producing pyrimidine compound |
| 12/22/2010 | EP2264015A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof |
| 12/22/2010 | EP2264013A1 Granular fabric softening compositions comprising a di-alkyl substituted imidazoline derivatives |
| 12/22/2010 | EP2262767A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 12/22/2010 | CN1988907B Dual small molecule inhibitors of cancer and angiogenesis |
| 12/22/2010 | CN1914208B Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives |
| 12/22/2010 | CN1809357B Small molecule Toll-like receptor (TLR) antagonists |
| 12/22/2010 | CN101925585A Novel quinazoline-2,4-dione derivative, and medical compositions for prophylaxis and treatment of cranial nerve disease containing the same |
| 12/22/2010 | CN101925584A Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, HIV, HPV, bacterial infections and dermatosis |
| 12/22/2010 | CN101925301A Tricyclic compounds as modulators of TNF-a synthesis and as pde4 inhibitors |
| 12/22/2010 | CN101921238A Preparation of substituted nitrogen-containing benzoheterocycle derivatives and pharmacological application thereof |
| 12/22/2010 | CN101921236A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 12/22/2010 | CN101921226A Substituted carboxylic ester compounds and application thereof |
| 12/22/2010 | CN101260107B Diheterocycle compound containing 4-thiazolidinone and pyrimidine, synthetic method and application thereof |
| 12/22/2010 | CN101128436B Glycine derivative and use thereof |
| 12/22/2010 | CN101119976B HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives |
| 12/22/2010 | CN101072779B 2,4 (4,6) pyrimidine derivatives |
| 12/22/2010 | CN101056864B Method for preparing pyrimidine compound |